These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36859809)

  • 21. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome.
    Yetim Şahin A; Baş F; Yetim Ç; Uçar A; Poyrazoğlu Ş; Bundak R; Darendeliler F
    Turk J Med Sci; 2019 Aug; 49(4):1117-1125. PubMed ID: 31286756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The polycystic ovary syndrome per se is not associated with increased chronic inflammation.
    Möhlig M; Spranger J; Osterhoff M; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Eur J Endocrinol; 2004 Apr; 150(4):525-32. PubMed ID: 15080783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
    Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
    Samy N; Hashim M; Sayed M; Said M
    Dis Markers; 2009; 26(4):163-70. PubMed ID: 19729797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.
    Ezeh U; Arzumanyan Z; Lizneva D; Mathur R; Chen YH; Boston RC; Chen YI; Azziz R
    Hum Reprod; 2019 Feb; 34(2):335-344. PubMed ID: 30576500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study.
    Wang Y; Zhou W; Wu C; Zhang Y; Lin T; Sun Y; Liu W; Tao T
    Reprod Biol Endocrinol; 2018 Mar; 16(1):31. PubMed ID: 29587769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome.
    Kelly CJ; Lyall H; Petrie JR; Gould GW; Connell JM; Rumley A; Lowe GD; Sattar N
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3287-90. PubMed ID: 12107238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance and oxidative marker in women with PCOS.
    Bannigida DM; Nayak BS; Vijayaraghavan R
    Arch Physiol Biochem; 2020 May; 126(2):183-186. PubMed ID: 30450993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    Satyaraddi A; Cherian KE; Kapoor N; Kunjummen AT; Kamath MS; Thomas N; Paul TV
    J Hum Reprod Sci; 2019; 12(2):78-84. PubMed ID: 31293320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galanin-like peptide and its correlation with androgen levels in patients with polycystic ovary syndrome.
    Demirpence M; Yilmaz Yasar H; Karakoyun I; Girgin EM
    Endokrynol Pol; 2023; 74(2):197-202. PubMed ID: 37155301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics.
    Kalyan S; Goshtesabi A; Sarray S; Joannou A; Almawi WY
    BMJ Open; 2018 Oct; 8(10):e021860. PubMed ID: 30368447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of Trace Elements in Erythrocytes as Endocrine Disruptors in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    Pokorska-Niewiada K; Brodowska A; Brodowski J; Szczuko M
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.